Evidence map›Paper›PMID 22553498›Full record

ReviewCold Spring Harbor perspectives in medicine2012

Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

Michael A Brehm, Alvin C Powers, Leonard D Shultz, Dale L Greiner

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2020
    Article
  7. Article
  8. Article
  9. Recovery of viable endocrine-specific cells and transcriptomes from human pancreatic islet-engrafted mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael A BrehmUniversity of Massachusetts Medical School, Program in Molecular Medicine, Worcester, Massachusetts, USA.
Alvin C Powers
Leonard D Shultz
Dale L Greiner

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
Coordinating Center for Beta Cell Biology ConsortiumU01DK072473 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2005 to 2014
$61.0M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 1986 to 2011
$28.1M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
UMASS MEDICAL CENTER FOR AIDS RESEARCHP30AI042845 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 1998 to 2012
$13.0M
Molecular Mechanisms of Human and Murine Beta Cell Proliferation and RegenerationU01DK089572 · NIDDK · VANDERBILT UNIVERSITY · PI GREINER, DALE LESLIE, HARLAN, DAVID MARSHALL · 2010 to 2014
$8.4M
Adaptive immunity in virus-induced diabetes in BBDR ratsU01AI073871 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 2006 to 2011
$2.9M
Molecular Genetics and Mechanisms of ThrombocytopeniaR01HL077642 · NHLBI · JACKSON LABORATORY · PI SHULTZ, LEONARD D. · 2004 to 2007
$1.7M
GLP-1 to Enhance Islet TransplantationR33DK066636 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 2005 to 2007
$1.5M
VEGF and Islet VascularizationR01DK069603 · NIDDK · VANDERBILT UNIVERSITY · PI POWERS, ALVIN C · 2005 to 2010
$1.3M
BLRD VA I01 BX000666NCI NIH HHS CA34196NCI NIH HHS P30 CA034196NHLBI NIH HHS HL077642NHLBI NIH HHS R01 HL077642NIAID NIH HHS AI073871NIAID NIH HHS AI083911NIAID NIH HHS AI46629NIAID NIH HHS P01 AI046629NIAID NIH HHS P30 AI042845NIAID NIH HHS R21 AI083911NIAID NIH HHS U01 AI073871NIDDK NIH HHS DK20593NIDDK NIH HHS DK32520NIDDK NIH HHS DK66636NIDDK NIH HHS DK68854NIDDK NIH HHS DK69603NIDDK NIH HHS DK72473NIDDK NIH HHS DK89572NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK032520NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK068764NIDDK NIH HHS R01 DK069603NIDDK NIH HHS R21 DK066636NIDDK NIH HHS R21 DK068854NIDDK NIH HHS R33 DK066636NIDDK NIH HHS U01 DK072473NIDDK NIH HHS U01 DK089572
6 · The paper itself

Abstract

Despite decades of studying rodent models of type 1 diabetes (T1D), no therapy capable of preventing or curing T1D has successfully been translated from rodents to humans. This inability to translate otherwise promising therapies to clinical settings likely resides, to a major degree, from significant species-specific differences between rodent and human immune systems as well as species-related variances in islets in terms of their cellular composition, function, and gene expression. Indeed, taken collectively, these differences underscore the need to define interactions between the human immune system with human β cells. Immunodeficient mice engrafted with human immune systems and human β cells represent an interesting and promising opportunity to study these components in vivo. To meet this need, years of effort have been extended to develop mice depleted of undesirable components while at the same time, allowing the introduction of constituents necessary to recapitulate physiological settings as near as possible to human T1D. With this, these so-called "humanized mice" are currently being used as a preclinical bridge to facilitate identification and translation of novel discoveries to clinical settings.

Indexed as

Disease Models, AnimalAnimalsAutoimmunityCell ProliferationDiabetes Mellitus, Type 1HumansHyperglycemiaIslets of LangerhansMiceMice, Inbred NODMice, SCIDReceptors, Interleukin-2Transplantation, HeterologousReceptors, Interleukin-2

Identifiers

PMID22553498
PMCPMC3331686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.